A working protocol to be used as a guideline for trials in multiple sclerosis.

Suppr

超能文献

作者信息

Weiner H L, Ellison G W

出版信息

Arch Neurol. 1983 Oct 21;40(11):704-10. doi: 10.1001/archneur.1983.04050100044018.

DOI:10.1001/archneur.1983.04050100044018

PMID:6625981

Abstract

摘要

相似文献

A working protocol to be used as a guideline for trials in multiple sclerosis.

Arch Neurol. 1983 Oct 21;40(11):704-10. doi: 10.1001/archneur.1983.04050100044018.

Critique of experimental trials of therapy in multiple sclerosis.

Neurology. 1974 Nov;24(11):1010-4. doi: 10.1212/wnl.24.11.1010.

Intrathecal interferon as treatment of multiple sclerosis. A planned multicenter study.

Arch Neurol. 1983 Oct 21;40(11):683-6. doi: 10.1001/archneur.1983.04050100023008.

Patient selection and criteria.

Arch Neurol. 1983 Oct 21;40(11):701. doi: 10.1001/archneur.1983.04050100041015.

Development of simple trial protocols.

Arch Neurol. 1983 Oct 21;40(11):700. doi: 10.1001/archneur.1983.04050100040014.

Choice of therapeutic agents for trial.

Arch Neurol. 1983 Oct 21;40(11):695-6. doi: 10.1001/archneur.1983.04050100035012.

Scoring techniques and problems in the evaluation of change in patients.

Arch Neurol. 1983 Oct 21;40(11):675-7. doi: 10.1001/archneur.1983.04050100015005.

Common problems in designing therapeutic trials in multiple sclerosis.

Arch Neurol. 1983 Oct 21;40(11):678-80. doi: 10.1001/archneur.1983.04050100018006.

Outcome measures in multiple sclerosis clinical trials.

Baillieres Clin Neurol. 1997 Oct;6(3):409-28.

Transfer factor treatment of multiple sclerosis. A pilot study.

Acta Neurol Scand Suppl. 1977;63:253-64.

引用本文的文献

Iron chelation and multiple sclerosis.

ASN Neuro. 2014 Jan 30;6(1):e00136. doi: 10.1042/AN20130037.

Prolonged dynamic clinico-immunological observation of 85 patients with definite multiple sclerosis: first steps towards monitoring process activity.

J Neurol. 1994 Jul;241(8):500-10. doi: 10.1007/BF00919713.

Multiple sclerosis: failure of treatment with verapamil in a pilot trial.

J Neurol. 1986 Feb;233(1):59-60. doi: 10.1007/BF00313996.

Short-term intensive cyclophosphamide treatment in progressive multiple sclerosis.

Ital J Neurol Sci. 1987 Dec;8(6):589-92. doi: 10.1007/BF02333666.

Effectiveness of azathioprine treatment in multiple sclerosis.

Ital J Neurol Sci. 1988 Jun;9(3):261-4. doi: 10.1007/BF02334050.

T-cell receptor V alpha and C alpha alleles associated with multiple and myasthenia gravis.

Proc Natl Acad Sci U S A. 1989 Feb;86(3):988-92. doi: 10.1073/pnas.86.3.988.

Susceptibility to multiple sclerosis associated with an immunoglobulin gamma 3 restriction fragment length polymorphism.

J Clin Invest. 1987 Jan;79(1):309-13. doi: 10.1172/JCI112801.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

A working protocol to be used as a guideline for trials in multiple sclerosis.

Arch Neurol. 1983 Oct 21;40(11):704-10. doi: 10.1001/archneur.1983.04050100044018.

Critique of experimental trials of therapy in multiple sclerosis.

Neurology. 1974 Nov;24(11):1010-4. doi: 10.1212/wnl.24.11.1010.

Intrathecal interferon as treatment of multiple sclerosis. A planned multicenter study.

Arch Neurol. 1983 Oct 21;40(11):683-6. doi: 10.1001/archneur.1983.04050100023008.

Patient selection and criteria.

Arch Neurol. 1983 Oct 21;40(11):701. doi: 10.1001/archneur.1983.04050100041015.

Development of simple trial protocols.

Arch Neurol. 1983 Oct 21;40(11):700. doi: 10.1001/archneur.1983.04050100040014.

Choice of therapeutic agents for trial.

Arch Neurol. 1983 Oct 21;40(11):695-6. doi: 10.1001/archneur.1983.04050100035012.

Scoring techniques and problems in the evaluation of change in patients.

Arch Neurol. 1983 Oct 21;40(11):675-7. doi: 10.1001/archneur.1983.04050100015005.

Common problems in designing therapeutic trials in multiple sclerosis.

Arch Neurol. 1983 Oct 21;40(11):678-80. doi: 10.1001/archneur.1983.04050100018006.

Outcome measures in multiple sclerosis clinical trials.

Baillieres Clin Neurol. 1997 Oct;6(3):409-28.

Transfer factor treatment of multiple sclerosis. A pilot study.

Acta Neurol Scand Suppl. 1977;63:253-64.

引用本文的文献

Iron chelation and multiple sclerosis.

ASN Neuro. 2014 Jan 30;6(1):e00136. doi: 10.1042/AN20130037.

Prolonged dynamic clinico-immunological observation of 85 patients with definite multiple sclerosis: first steps towards monitoring process activity.

J Neurol. 1994 Jul;241(8):500-10. doi: 10.1007/BF00919713.

Multiple sclerosis: failure of treatment with verapamil in a pilot trial.

J Neurol. 1986 Feb;233(1):59-60. doi: 10.1007/BF00313996.

Short-term intensive cyclophosphamide treatment in progressive multiple sclerosis.

Ital J Neurol Sci. 1987 Dec;8(6):589-92. doi: 10.1007/BF02333666.

Effectiveness of azathioprine treatment in multiple sclerosis.

Ital J Neurol Sci. 1988 Jun;9(3):261-4. doi: 10.1007/BF02334050.

T-cell receptor V alpha and C alpha alleles associated with multiple and myasthenia gravis.

Proc Natl Acad Sci U S A. 1989 Feb;86(3):988-92. doi: 10.1073/pnas.86.3.988.

Susceptibility to multiple sclerosis associated with an immunoglobulin gamma 3 restriction fragment length polymorphism.

J Clin Invest. 1987 Jan;79(1):309-13. doi: 10.1172/JCI112801.